Advertisement

VEGF-RII nicht aber VEGF-RI Expression korreliert mit Tumordifferenzierung, Angiogenese und Tumorzell-Wachstum beim Pankreaskazinom

  • P. Büchler
  • H. Friess
  • M. W. Müller
  • H. A. Reber
  • O. J. Hines
  • M. W. Büchler
Conference paper
Part of the Deutsche Gesellschaft für Chirurgie book series (DTGESCHIR, volume 31)

Abstract

Vascular endothelial growth factor (VEGF) and its receptors are key regulators of tumor neoangiogenesis. VEGF is overexpressed in human pancreatic cancer (PaCa), its receptors, however, were thought to be expressed by endothelial cells only. In the present study we further investigated expression of VEGF-RI and -RII in human pancreatic cancer and evaluated cancer cell proliferation during antisense oligonucleotide treatment against both VEGF receptors. The majority of cancer specimens expressed VEGF-RI and VEGF-RII mRNA. Both receptors were found in blood vessels as well as in cancer cells. The presence of VEGF-RII correlated with poor tumor differentiation. Pancreatic cancer cell lines increased DNA synthesis upon VEGF stimulation, which was inhibited by antisense oligonucleotides against VEGF-RII, but not by those against VEGF-RI. Therefore VEGF represents an autocrine growth factor in human pancreatic cancer. VEGF-RII appears to be a key protein in angiogenesis and mitogenesis and its blockade offers a new therapeutic target.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. (1998) Cancer statistics by race and ethnicity.Ca: a Cancer Journal for Clinicians48: 31 -48CrossRefGoogle Scholar
  2. 2.
    Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler MW. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358: 1576-85PubMedCrossRefGoogle Scholar
  3. 3.
    Skobe M, Rockwell P, Goldstein N, Vosseier S, Fusenig NE. (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nature Medicine 1222 - 7Google Scholar
  4. 4.
    Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Møller NP, Risau W, Ullrich A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72(6): 835 - 46PubMedCrossRefGoogle Scholar
  5. 5.
    Itakura J, Ishiwata T, Friess H, Fujii H, Matsumoto Y, Büchler M, Korc M. (1997) Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.Clinical Cancer Research3: 1309- 16PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • P. Büchler
    • 1
    • 3
  • H. Friess
    • 1
  • M. W. Müller
    • 1
  • H. A. Reber
    • 2
  • O. J. Hines
    • 2
  • M. W. Büchler
    • 1
  1. 1.Abteilung für Allgemeine, Viszerale, Unfallchirurgie und Poliklinik, Chirurgische UniversitätsklinikUniversität HeidelbergGermany
  2. 2.Department of SurgeryUniversity of California at Los Angeles, School of MedicineCaliforniaUSA
  3. 3.Abteilung für Allgemeine, Viszerale, Unfallchirurgie und Poliklinik, Chirurgische UniversitätsklinikUniversität Heidelberg,HeidelbergGermany

Personalised recommendations